Emily Jackson

Emily Jackson is a Professor of Medical Law at the London School of Economics (LSE) Law School, where she has been affiliated since 1998. Her expertise spans medical law and ethics, with a focus on reproductive rights, end-of-life decision-making, and pharmaceutical regulation. She holds a first degree from Oxford University and has taught at institutions including Cambridge, Birkbeck College, and Queen Mary, University of London.

Her research addresses contentious issues such as assisted conception, embryo research ethics, and the legal implications of medical technologies. She has held significant roles, including Deputy Chair of the Human Fertilisation and Embryology Authority (2008–2012), Judicial Appointments Commissioner (2014–2017), and membership in the British Medical Association Medical Ethics Committee (2005–present). She is a Fellow of the British Academy and received an OBE in 2017 for contributions to higher education.

Her work explores the interplay between law, ethics, and medicine, with notable publications like *Medical Law: Text, Cases and Materials* (Oxford UP, 2022) and *The 14 Day Rule and Human Embryo Research* (Routledge, 2024). Her recent articles analyze UK regulatory challenges in brain organoid research and the ethical impact of pharmaceutical industry corporatization.

• Education: Oxford University
• Key Roles: Judicial Appointments Commissioner, HFEA Deputy Chair, British Medical Association Ethics Committee
• Editorial Boards: *Medical Law International*, *Health Economics, Policy and Law*, *Biosocieties*
• Grants/Advisory Work: EU Framework Programme Ethics Review, MRC Ethics Committee

Her advocacy extends to reforming end-of-life laws and addressing inequalities in healthcare access. She critiques legal frameworks that fail to account for evolving biotechnologies and patient autonomy.